Notice of Intent To Grant Exclusive License of the United States Patent No. 7,837,654 B2, Issued November 23, 2010 Entitled: Precision Sensing and Treatment Delivery Device for Promoting Healing in Living Tissue, 50089 [2012-20354]
Download as PDF
<![CDATA[
mstockstill on DSK4VPTVN1PROD with NOTICES
Federal Register / Vol. 77, No. 161 / Monday, August 20, 2012 / Notices
Meeting from 7:30 a.m. to 9 a.m. to
discuss administrative matters of the
Panel. The Administrative Work
Meeting will be held at the Naval
Heritage Center, 701 Pennsylvania
Avenue, NW., Washington, DC 20004.
Pursuant to 41 CFR 102–3.160, the
Administrative Work Meeting will be
closed to the public.
Written Statements: Pursuant to 41
CFR 102–3.105(j) and 102–3.140, the
public or interested organizations may
submit written statements to the
membership of the Panel at any time or
in response to the stated agenda of a
planned meeting. Written statements
should be submitted to the Panel’s
Designated Federal Officer (DFO). The
DFO’s contact information can be
obtained from the General Services
Administration’s Federal Advisory
Committee Act Database at https://
www.fido.gov/facadatabase/public.asp.
Written statements that do not pertain
to the scheduled meeting of the Panel
may be submitted at any time. However,
if individual comments pertain to a
specific topic being discussed at a
planned meeting, then these statements
must be submitted no later than 5
business days prior to the meeting in
question. The DFO will review all
submitted written statements and
provide copies to all the committee
members.
Public Comments: In addition to
written statements, the Panel will set
aside 1 hour for individuals or
interested groups to address the Panel.
To ensure consideration of their
comments, individuals and interested
groups should submit written
statements as outlined in this notice; but
if they still want to address the Panel,
then they will be afforded the
opportunity to register to address the
Panel. The Panel’s DFO will have a
‘‘Sign-Up Roster’’ available at the Panel
meeting for registration on a first-come,
first-serve basis. Those wishing to
address the Panel will be given no more
than 5 minutes to present their
comments, and at the end of the 1 hour
time period, no further public
comments will be accepted. Anyone
who signs-up to address the Panel, but
is unable to do so due to the time
limitation, may submit their comments
in writing; however, they must
understand that their written comments
may not be reviewed prior to the Panel’s
deliberation.
To ensure timeliness of comments for
the official record, the Panel encourages
that individuals and interested groups
consider submitting written statements
instead of addressing the Panel.
VerDate Mar<15>2010
16:25 Aug 17, 2012
Jkt 226001
Dated: August 15, 2012.
Aaron Siegel,
Alternate OSD Federal Register Liaison
Officer, Department of Defense.
[FR Doc. 2012–20413 Filed 8–17–12; 8:45 am]
BILLING CODE 5001–06–P
50089
microtubes and sensing fibers therein
for evaluating and treating cell tissue.
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2012–20354 Filed 8–17–12; 8:45 am]
BILLING CODE 3710–08–P
DEPARTMENT OF DEFENSE
DEPARTMENT OF DEFENSE
Department of the Army
Department of the Army
Notice of Intent To Grant Exclusive
License of the United States Patent No.
7,837,654 B2, Issued November 23,
2010 Entitled: Precision Sensing and
Treatment Delivery Device for
Promoting Healing in Living Tissue
Department of the Army, DoD.
ACTION: Notice of intent.
AGENCY:
In accordance with 37 CFR
404.7(a)(1)(i), announcement is made of
a prospective exclusive license of the
following U.S. Patent #7,837,654 B2,
issued November 23, 2010, to OPTS,
Inc., a Huntsville, Alabama company.
DATES: Written objections must be filed
not later than 15 days following
publication of this announcement.
ADDRESSES: United States Army
Aviation & Missile Research
Development & Engineering Center,
Attn: RDMR–CST (Dr. J.R. Alexander),
5400 Fowler Road, Redstone Arsenal,
Alabama 35898–5000.
FOR FURTHER INFORMATION CONTACT: Dr.
Russ Alexander, Chief, Office of
Research and Technology Applications,
(256) 876–8743, email:
russ.alexander@us.army.mil
SUMMARY:
This
patent abstract claims a microneedle
insertable in a target cell tissue,
including a manipulative end
maintained exterior of cell tissue and an
insertion end positionable in or adjacent
of target cell tissue. A plurality of
microtubes are bundled to pass through
the needle body and extend to
respective distal ends grouped
proximally interior of the insertion end.
A sensing fiber is extendable from
means for sensing for passage through
the needle body to a distal end capable
of sensing cell tissue parameters. The
insertion end and the bundled
microtube and sensing fiber distal ends
are positionable in or adjacent of cell
tissue thereby providing rapid
evaluation of cell parameters by optic
fiber sensing, fiber sampling of cell
parameters, and precise delivery of
therapeutic fluids or additional
treatment measures. A method is also
disclosed of precisely positioning a
microneedle having a plurality of
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00012
Fmt 4703
Sfmt 4703
Army Education Advisory Committee
Meeting
Department of the Army, DoD.
Notice of open meeting.
AGENCY:
ACTION:
Pursuant to the Federal
Advisory Committee Act of 1972 (5
U.S.C., Appendix, as amended), the
Sunshine in the Government Act of
1976 (U.S.C. 552b, as amended) and 41
Code of the Federal Regulations (CFR
102–3. 140 through 160, the Department
of the Army announces the following
committee meeting:
Name of Committee: Army Education
Advisory Committee (AEAC).
Date of Meeting: September 4–5, 2012.
Time of Meeting: 0800–1600.
Place of Meeting: TRADOC HQ, 950
Jefferson Ave, Building 950, Conference
Room 2047, 2rd Floor, Ft Eustis, VA.
Proposed Agenda: Purpose of the
meeting is to gather and review
information, discuss, and deliberate
issues related to shifting Army training
from an instructor-centric to a learnercentric paradigm required by the Army
2020 learning environment. The agenda
will include topics relating to Army
Learning Model 2015 and support to
essential proficiencies and professional
development plan for facilitators.
Additionally, recommendations
submitted by subcommittees will be
discussed and deliberated.
FOR FURTHER INFORMATION CONTACT: For
information please contact Mr. Wayne
Joyner, Designated Federal Officer, at
albert.w.joyner.civ@mail.mil, (757) 501–
5810, or to the following address: Army
Education Advisory Committee,
Designated Federal Officer, ATTN:
ATTG–OPS–EO (Joyner), 950 Jefferson
Ave, Building 950, Ft Eustis, Virginia
23604.
SUMMARY:
Meeting of
the Advisory Committee is open to the
public and any member of the public
wishing to attend this meeting should
contact the Designated Federal Officer
previously listed at least ten calendar
days prior to the meeting for
information on base entry. Individuals
without a DoD Government Common
Access Card require an escort at the
SUPPLEMENTARY INFORMATION:
E:\FR\FM\20AUN1.SGM
20AUN1
]]>Agencies
[Federal Register Volume 77, Number 161 (Monday, August 20, 2012)]
[Notices]
[Page 50089]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-20354]
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Department of the Army
Notice of Intent To Grant Exclusive License of the United States
Patent No. 7,837,654 B2, Issued November 23, 2010 Entitled: Precision
Sensing and Treatment Delivery Device for Promoting Healing in Living
Tissue
AGENCY: Department of the Army, DoD.
ACTION: Notice of intent.
-----------------------------------------------------------------------
SUMMARY: In accordance with 37 CFR 404.7(a)(1)(i), announcement is made
of a prospective exclusive license of the following U.S. Patent
7,837,654 B2, issued November 23, 2010, to OPTS, Inc., a
Huntsville, Alabama company.
DATES: Written objections must be filed not later than 15 days
following publication of this announcement.
ADDRESSES: United States Army Aviation & Missile Research Development &
Engineering Center, Attn: RDMR-CST (Dr. J.R. Alexander), 5400 Fowler
Road, Redstone Arsenal, Alabama 35898-5000.
FOR FURTHER INFORMATION CONTACT: Dr. Russ Alexander, Chief, Office of
Research and Technology Applications, (256) 876-8743, email:
russ.alexander@us.army.mil
SUPPLEMENTARY INFORMATION: This patent abstract claims a microneedle
insertable in a target cell tissue, including a manipulative end
maintained exterior of cell tissue and an insertion end positionable in
or adjacent of target cell tissue. A plurality of microtubes are
bundled to pass through the needle body and extend to respective distal
ends grouped proximally interior of the insertion end. A sensing fiber
is extendable from means for sensing for passage through the needle
body to a distal end capable of sensing cell tissue parameters. The
insertion end and the bundled microtube and sensing fiber distal ends
are positionable in or adjacent of cell tissue thereby providing rapid
evaluation of cell parameters by optic fiber sensing, fiber sampling of
cell parameters, and precise delivery of therapeutic fluids or
additional treatment measures. A method is also disclosed of precisely
positioning a microneedle having a plurality of microtubes and sensing
fibers therein for evaluating and treating cell tissue.
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2012-20354 Filed 8-17-12; 8:45 am]
BILLING CODE 3710-08-P
